Tumor necrosis factor-α confers resistance to hypoxic injury in the adult mammalian cardiac myocyte

Circulation

Volumn 97, Issue 14, 1998, Pages 1392-1400

  Nakano, Masayuki ^a   Knowlton, Anne A ^a   Dibbs, Ziad ^a   Mann, Douglas L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Genes; Hypoxia; Myocytes; Proteins

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALCIUM 45; CALCIUM ION; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CELL DAMAGE; CONTROLLED STUDY; HEART FAILURE; HEART MUSCLE CELL; HEAT SHOCK; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032515948     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.14.1392     Document Type: Article

References (62)

1. Tovey MG. Expression of the genes of interferons and other cytokines in normal and diseased tissues of man. Experientia. 1989;45:526-534.
2. Tovey MG, Content J, Gresser I, Gugenheim J, Blanchard B, Guymarho J, Poupart P, Gigou M, Shaw A, Fiers W. Genes for IFN-β-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals. J Immunol. 1988;141:3106-3110.
3. Hunt JS, Chen HL, Hu XL, Chen TY, Morrison DC. Tumor necrosis factor-α gene expression in the tissues of normal mice. Cytokine. 1992;4:340-346.
4. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD, Shires GT. Shock and tissue injury induced by recombinant human cachectin. Science. 1986;234:470-474.
5. Lowry SF. Modulating the metabolic response to injury and infection. Proc Nutr Soc. 1992;51:267-277.
6. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987;50:555-563.
7. Tracey KJ, Lowry SF, Fahey TJ III, Albert JD, Fong Y, Hesse DG, Beutler B, Manogue KR, Calvano S, Cerami A, Shires GT. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet. 1987;164:415-422.
8. Bader T, Wietzerbin J. Nuclear accumulation of interferon gamma. Proc Natl Acad Sci U S A. 1994;91:11831-11835.
9. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest. 1992;90:693-698.
10. Giroir BP, Horton JW, White JD, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol. 1994;267:H118-H124.
11. Eddy LJ, Goeddel DV, Wong GHW. Tumor necrosis factor-α pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun. 1992;184:1056-1059.
12. Low-Friedrich I, Weisensee D, Mitrou P, Schoeppe W. Cytokines induce stress protein formation in cultured cardiac myocytes. Basic Res Cardiol. 1992;87:12-18.
13. Nakano M, Knowlton AA, Yokoyama T, Lesslauer W, Mann DL. Tumor necrosis factor-α induced expression of heat shock protein 72 in adult feline cardiac myocytes. Am J Physiol. 1996;270:H1231-H1239.
14. Knowlton AA. The role of heat shock proteins in the heart. J Mol Cell Cardiol. 1995;27:121-131.
15. Knowlton AA. Heat-shock proteins, stress, and the heart. Ann N Y Acad Sci. 1994;723:128-137.
16. Mann DL, Kent RL, Cooper G IV. Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation. Circ Res. 1989;64:1079-1090.
17. Mann DL, Urabe Y, Kent RL, Vinciguerra S, Cooper G IV. Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium. Circ Res. 1991;68:402-415.
18. Mann DL, Kent RL, Parsons B, Cooper G IV. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992;85:790-804.
19. Welder AA. A primary culture system of adult rat heart cells for the evaluation of cocaine toxicity. Toxicology. 1992;72:175-187.
20. Mossmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods. 1983;65:55-63.
21. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 1993;92:2303-2312.
22. Nakano M, Mann DL, Knowlton AA. Blocking the endogenous increase in HSP 72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiocytes. Circulation. 1997;95:1523-1531.
23. Loetscher H, Stueber D, Banner D, Mackay F, Lesslauer W. Human tumor necrosis factor α (TNFα) mutants with exclusive specificity for the 55-kDa or 75 kDA TNF receptors. J Biol Chem. 1993;268:26350-26357.
24. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation. 1995;92:1487-1493.
25. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman ML, Mann DL. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation. 1997;95:1247-1252.
26. Wong GHW, Goeddel DV. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science. 1988;242:941-944.
27. Wong GHW, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 1989;58:923-931.
28. Hammond GL, Wieben E, Markert CL. Molecular signals for initiating protein synthesis in organ hypertrophy. Proc Natl Acad Sci U S A. 1979; 76:2455-2459.
29. Hammond GL, Lai YK, Markert CL. The molecules that initiate cardiac hypertrophy are not species specific. Science. 1982;216:529-531.
30. Casscells W, Speir E, Sasse J, Klagsbrun M, Allen P, Lee M, Calvo B, Chiba M, Haggroth L, Folkman J, Epstein SE. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest. 1990;85:433-441.
31. 1, in the normal rat myocardium. Tissue Res. 1989;256:553-558.
32. Weiner HL, Swain JL. Acidic fibroblast growth factor mRNA is expressed by cardiac myocytes in culture and the protein is localized to the extracellular matrix. Proc Natl Acad Sci U S A. 1989;86:2683-2687.
33. Sen S, Kundu G, Mekhail N, Castel J, Misono K, Healy B. Myotrophin: purification of a novel peptide from spontaneously hypertensive rat heart that influences myocardial growth. J Biol Chem. 1990;265:16635-16643.
34. Long CS, Henrich CJ, Simpson PC. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regul. 1991;2:1081-1095.
35. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res. 1993;72:1245-1254.
36. 1 receptor subtype. Circ Res. 1993;73:413-423.
37. Sadoshima JI, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
38. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ, Parker PJ, Sugden PH. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes: the potential role of the cascade in the integration of 2 signaling pathways leading to myocyte hypertrophy. J Biol Chem. 1994;269:1110-1119.
39. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Marumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin-II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993;92:398-403.
40. Sugden PH, Fuller SJ, Mynett JR, Hatchett RJ, Bogoyevitch MA, Sugden MC. Stimulation of adult rat ventricular myocyte protein synthesis and phosphoinositide hydrolysis by the endothelins. Biochim Biophys Acta. 1993;1175:327-332.
41. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 1991;69:209-215.
42. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke 'fetal' contractile protein gene expression in rat cardiac myocytes. J Clin Invest. 1990;85:507-514.
43. Kapadia S, Lee JR, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995;96:1042-1052.
44. Maury CPJ, Teppo AM. Circulating tumour necrosis factor-α (cachectin) in myocardial infarction. J Intern Med. 1989;225:333-336.
45. Basaran Y, Basaran MM, Babacan KF, Ener B, Okay T, Gok H, Ozdemir M. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology. 1993;44:332-337.
46. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561-566.
47. Lefer AM, Tsao P, Aoki N, Palladino MA Jr. Mediation of cardioprotection by transforming growth factor-β. Science. 1990;249:61-64.
48. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995; 146:419-428.
49. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;223:236-241.
50. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
51. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992;105:575-580.
52. Pabla R, Curtis MJ. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart. Circ Res. 1995;77:984-992.
53. Nakata T, Suzuki K, Fujii J, Ishikawa M, Taniguchi N. Induction and release of manganese superoxide dismutase from mitochondria of human umbilical vein endothelial cells by tumor necrosis factor-alpha and interleukin-1 alpha. Int J Cancer. 1993;55:646-650.
54. Eichenholz PW, Eichacker PQ, Hoffman WD, Banks SM, Parrillo JE, Danner RL, Natanson C. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol. 1992;263:H668-H675.
55. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321:280-287.
56. Natanson C, Eichenholz PW, Danner RL, Eichacker W, Hoffman D, Kuo SM, Banks TJ, MacViottie TJ, Parrillo JE. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med. 1989;169:823-832.
57. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest. 1992;90:389-398.
58. Mann DL, Lee-Jackson D, Yokoyama T. Tumor necrosis factor-alpha and cardiac remodeling. Heart Failure. 1995;August/September:166-175.
59. Morgan MJ, Palace GP, Everitt JE, Malik AB. TNF-α release in endotoxemia contributes to neutrophil-dependent pulmonary edema. Am J Physiol. 1993;264:H1161-H1165.
60. Millar AB, Singer M, Meager A, Foley NM, Johnson NM, Rook GA. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet. 1989;2:712-713.
61. Stephens KE, Ishizaka A, Larrick JW, Raffm TA. Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis. 1988;137:1364-1370.
62. Lo SK, Everitt J, Gu J, Mailk AB. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest. 1992;89:981-988.